Eli Lilly does not expect drug shortages due to coronavirus
In this article:
March 3 (Reuters) - U.S. drugmaker Eli Lilly and Co said on Tuesday it does not expect the coronavirus outbreak to result in shortages for any of its therapies, including all forms of insulin.
The company said it does not source active drug ingredients from China for any of its approved medicines and that its insulin manufacturing facilities in the United States and Europe have not been impacted by the outbreak. (Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Arun Koyyur)
